Catherine Dhiver

Multidrug Resistance Genotypes (Insertions in the β3–β4 Finger Subdomain and MDR Mutations) of HIV-1 Reverse Transcriptase from Extensively Treated Patients: Incidence and Association with Other Resistance Mutations

Catherine Tamalet, Nouara Yahi, Christian Tourrès et al. · Virology · 2000 · 59 citations

Human Retrovirus, Hiv-1 Reverse Transcriptase, Immunology +7

Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non‐nucleoside reverse transcriptase inhibitor

Caroline Solas, Isabelle Poizot‐Martin, Marie‐Pierre Drogoul et al. · British Journal of Clinical Pharmacology · 2004 · 45 citations · Full text

Pilot phase I study using zidovudine in association with a 10-day course of anti-CD4 monoclonal antibody in seven AIDS patients

Catherine Dhiver, Daniel Olive, S. Rousseau et al. · AIDS · 1989 · 21 citations

Cd4+ Cells, Immunology, Immunotherapy +17

Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients

Nadège Néant, Minh Lê, Naïm Bouazza et al. · British Journal of Clinical Pharmacology · 2020 · 13 citations · Full text

Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine

Nadège Néant, Florence Gattacceca, Minh Lê et al. · European Journal of Clinical Pharmacology · 2018 · 11 citations

Translational Medicine, Treatment And Prevention, Pharmacology +9